Prediction of Volume Responsiveness in Presence of Left Ventricular Diastolic Dysfunction
- Conditions
- Hemodynamics
- Interventions
- Other: intubation and mechanical ventilationOther: central venous catheterOther: premedicationOther: transpulmonary thermodilution catheterOther: passive leg raisingOther: arterial catheterOther: transesophageal echocardiography
- Registration Number
- NCT02441621
- Lead Sponsor
- University Hospital Schleswig-Holstein
- Brief Summary
The ability of the global end-diastolic volume index (GEDVI), stroke volume variation (SVV) and pulse pressure variation (PPV) for prediction of fluid responsiveness in presence of left ventricular diastolic dysfunction is still unknown. The aim of the present study was to challenge the predictive power of GEDVI, SVV and PPV in cardiac surgery patients undergoing aortic valve replacement.
- Detailed Description
All patients receive premedication with midazolam 7.5 mg p.o.. After induction of anesthesia with sufentanil (0.5 µg/kg) and propofol (1.5 mg/kg), orotracheal intubation is facilitated with rocuronium (0.6 mg/kg). Anesthesia is maintained with sufentanil (1 µg/kg/h) and propofol (3 mg/kg/h) and patients are ventilated with an oxygen/air mixture in volume-controlled mode, using a tidal volume of 8 ml/kg related to the ideal body weight. Positive end-expiratory pressure is set at 5 cmH2O. Continuous monitoring is performed including electrocardiogram, radial arterial pressure catheter and a central venous catheter in the right or left internal jugular vein. Before placement of a transpulmonary thermodilution catheter a transesophageal echocardiography (TOE) is performed. TOE is used to detect diastolic dysfunction of the left ventricle and to exclude right ventricular dysfunction. In presence of left ventricular dysfunction a transpulmonary thermodilution catheter is placed in the femoral artery and connected to a PiCCO2 monitor (PiCCO2, Pulsion Medical Systems, Munich, Germany). Additionally capnography, urine output, temperature (blood, bladder and nasopharyngeal), airway pressure, and pulse oximetry are recorded.
Before starting operation a passive leg raising is performed. The passive leg raising maneuver (PLR) involves a leg elevation up to 45° with the trunk in a horizontal position and was performed to induce hemodynamic effects by a volume challenge, turning unstressed blood volume to stressed volume proportional to body size. In case of an increase of stroke volume index (SVI) \>15% during PLR, patients were defined as responders.
All patients were studied with no changes in anesthesia management. Measurements of SVI, GEDVI, SVV and PPV are performed before, during and after PLR. Thereafter, patients receive a fluid Bolus of 500 ml crystalloids. Again, measurements are performed before and after fluid replacement.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Patients > 18 yrs of age
- Patients with a left ventricular ejection fraction ≥0.5
- Patients with left ventricular diastolic dysfunction.
- Emergency procedures
- Right ventricular dysfunction
- Hemodynamic instability requiring pharmacologic Support
- Ongoing arrhythmia
- Intracardiac Shunts
- Severe mitral stenosis or insufficiency
- Aortic aneurysm > 4 cm
- Use of an artificial left ventricular assist device or intra - aortic balloon pump.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description intubation and mechanical ventilation intubation and mechanical ventilation - central venous catheter central venous catheter - premedication premedication - transpulmonary thermodilution catheter transpulmonary thermodilution catheter - Passive leg raising passive leg raising - arterial catheter arterial catheter Continuous monitoring is performed including electrocardiogram, radial arterial pressure catheter transesophageal echocardiography transesophageal echocardiography -
- Primary Outcome Measures
Name Time Method Increase in stroke volume index (SVI) >15% Patients will be obtained until the end of the operation, an expected average of 5 hours In presence of an increase of SVI \>15% during PLR and/or 500 ml crystalloids, patients are defined as responders.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ole Broch
🇩🇪Kiel, Schleswig-Holstein, Germany